Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP208203.RAuoCCBgnHZTg3usUauJyvSjDsqaVKusY2a2brBTNHzEA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP208203.RAuoCCBgnHZTg3usUauJyvSjDsqaVKusY2a2brBTNHzEA130_assertion type Assertion NP208203.RAuoCCBgnHZTg3usUauJyvSjDsqaVKusY2a2brBTNHzEA130_head.
- NP208203.RAuoCCBgnHZTg3usUauJyvSjDsqaVKusY2a2brBTNHzEA130_assertion description "[Loss of imprinting at insulin-like growth factor II (IGFII), in association with H19 silencing, has been described previously in a subgroup of Beckwith-Wiedemann syndrome (BWS) patients who have an elevated risk for Wilms' tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208203.RAuoCCBgnHZTg3usUauJyvSjDsqaVKusY2a2brBTNHzEA130_provenance.
- NP208203.RAuoCCBgnHZTg3usUauJyvSjDsqaVKusY2a2brBTNHzEA130_assertion evidence source_evidence_literature NP208203.RAuoCCBgnHZTg3usUauJyvSjDsqaVKusY2a2brBTNHzEA130_provenance.
- NP208203.RAuoCCBgnHZTg3usUauJyvSjDsqaVKusY2a2brBTNHzEA130_assertion SIO_000772 17325026 NP208203.RAuoCCBgnHZTg3usUauJyvSjDsqaVKusY2a2brBTNHzEA130_provenance.
- NP208203.RAuoCCBgnHZTg3usUauJyvSjDsqaVKusY2a2brBTNHzEA130_assertion wasDerivedFrom befree-20140225 NP208203.RAuoCCBgnHZTg3usUauJyvSjDsqaVKusY2a2brBTNHzEA130_provenance.
- NP208203.RAuoCCBgnHZTg3usUauJyvSjDsqaVKusY2a2brBTNHzEA130_assertion wasGeneratedBy ECO_0000203 NP208203.RAuoCCBgnHZTg3usUauJyvSjDsqaVKusY2a2brBTNHzEA130_provenance.